PDS Biotechnology (NASDAQ:PDSB – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at HC Wainwright in a research report issued on Friday,Benzinga reports. They presently have a $21.00 target price on the stock. A number of other research analysts have also recently weighed in on PDSB. Alliance Global Partners raised shares of […]

Curis (NASDAQ:CRIS – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a research note issued on Friday,Benzinga reports. They currently have a $20.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective suggests a potential upside of 398.75% from the company’s current price. Curis Stock […]